HEXO (NYSE:HEXO) is, once again, dipping into the investor well to obtain funds. The company announced Friday that it is raising gross proceeds of $20 million in a fresh issue of stock and warrants, effected through a registered direct offering.

Specifically, the company will sell just under 12 million shares at an offering price of $1.67 apiece. Those snapping up the new stock will also receive warrants -- almost 6 million of these are to be disbursed. The warrants have an exercise price of $2.45 per share, with a five-year term.

Marijuana leaf atop a 100 dollar bill.

Image source: Getty Images

HEXO has made a series of secondary stock offerings within the past few years. Its shares outstanding count has more than tripled since late 2017; the latest tally is slightly over 272 million shares. The company is consistently unprofitable; in HEXO's most recently reported quarter, it posted an EBITDA shortfall of 66 million Canadian dollars ($51 million).

Prior to the announcement of the latest fundraising effort, HEXO's stock closed at $1.78 per share.

HEXO wasn't all that specific about how it'll utilize the proceeds of the issue, although it did write that among the uses will be "funding the Company's research and development to further advance the Company's innovation strategies."

The share and warrant issue is anticipated to close "on or about" Jan. 22, HEXO said.

Investors are not taking the news well, likely due to the dilutive effects of this latest round of financing and the general state of HEXO's finances. The marijuana stock is down by over 7% in late morning trading.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.